Autosomal recessive steroid-resistant nephrotic syndrome (NS) is a rare, genetically determined nephropathy caused mainly by a mutation in the NPHS2 gene. This type of NS is usually resistant to other immunosuppressive therapy as well, but a few cases of cyclosporine A-induced partial remission of inherited NS have been reported. We present a boy that developed NS at the age of 18 months. There was no decrease of proteinuria on standard prednisolone therapy, and a diagnosis of steroid-resistant NS was established. However, the proteinuria decreased significantly following the initiation of cyclosporine A therapy (from 1280 to 380 mg/m(2) per day) without any negative effects on renal function (stable glomerular filtration rate 130-150 ml/min per 1.73 m(2)). The molecular genetic test revealed a homozygous R138Q mutation in the NPHS2 gene. Our case demonstrates that cyclosporine A can induce partial remission in patients with genetic forms of NS without influencing the glomerular filtration rate. However, its long-term effect and safety in children with hereditary forms of nephrotic syndrome have yet to be investigated.

Department of Pediatrics 2nd Faculty of Medicine Charles University Prague Prague 5 Czech Republic

Zobrazit více v PubMed

Yonsei Med J. 2005 Feb 28;46(1):141-8 PubMed

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003594 PubMed

Kidney Int. 1999 Mar;55(3):1051-6 PubMed

Pediatrics. 2007 Apr;119(4):e907-19 PubMed

Nat Med. 2008 Sep;14(9):931-8 PubMed

Nephrol Dial Transplant. 2007 Aug;22(8):2183-93 PubMed

Pediatr Nephrol. 2008 Jan;23(1):63-70 PubMed

J Am Soc Nephrol. 2003 Mar;14(3):690-8 PubMed

J Am Soc Nephrol. 2004 Mar;15(3):722-32 PubMed

Pediatr Nephrol. 2007 Jan;22(1):57-63 PubMed

Genetic diagnosis of steroid-resistant nephrotic syndrome in a longitudinal collection of Czech and Slovak patients: a high proportion of causative variants in NUP93